Management of Warfarin Therapy with Topical Otic Medications

Warfarin Dosing and Monitoring

• The American College of Cardiology recommends continuing warfarin at the current dose without modification when initiating otic antibiotic therapy, with a target INR of 2.0 to 3.0 for atrial fibrillation management 1, 2, 3
• No additional INR monitoring is required beyond the patient's routine schedule when using topical otic medications, as stated by the American College of Cardiology 2

Stroke Prevention and Anticoagulation

• The American College of Cardiology advises against discontinuing or reducing warfarin dosing based on unfounded concerns about bleeding risk from topical otic medications, as the stroke prevention benefit of maintaining therapeutic anticoagulation far outweighs any theoretical risk 2, 3
• Approximately 23.5% of ischemic strokes in elderly patients with atrial fibrillation are attributable to AF, making continuous anticoagulation critically important, according to the American Geriatrics Society 4

Management of Warfarin in Elderly Patients with Atrial Fibrillation

Optimal Warfarin Management

• The American Geriatrics Society recommends maintaining an INR of 2.0-3.0, with a target of 2.5, for atrial fibrillation to provide maximum stroke protection while minimizing bleeding risk 5, 6
• For patients ≥75 years with atrial fibrillation, warfarin reduces stroke risk substantially, and interrupting therapy—even briefly—increases thromboembolic risk 5, 6
• Approximately 23.5% of ischemic strokes in elderly patients with atrial fibrillation are directly attributable to AF, making continuous anticoagulation critically important 5

Modifiable Bleeding Risk Factors

• Avoid concomitant aspirin or NSAIDs unless there is a compelling indication, as these medications double bleeding risk without additional stroke benefit in AF 6